Selected research
Industry Research
Syndromic Diagnostic Test Industry Research Report 2026
Market perspective
The global Syndromic Diagnostic Test market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Syndromic Diagnostic Test market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Syndromic Diagnostic Test market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Syndromic Diagnostic Test market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Syndromic Diagnostic Test include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin and bioMérieux and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Syndromic Diagnostic Test market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Syndromic Diagnostic Test.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Syndromic Diagnostic Test Market by Company
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Syndromic Diagnostic Test Segment by Type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Syndromic Diagnostic Test Segment by Application
Hospital
Laboratory
Research Institution
Others
Syndromic Diagnostic Test Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Syndromic Diagnostic Test market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Syndromic Diagnostic Test and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Syndromic Diagnostic Test.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Syndromic Diagnostic Test companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nucleic Acid Extraction Test
- Polymerase Chain Reaction (PCR) Test
- Others
Applications
- Hospital
- Laboratory
- Research Institution
- Others
Companies covered
- Abbott
- Hologic
- Applied BioCode
- Danaher
- Diagenode
- Curetis
- Bio-Rad
- DiaSorin
- bioMérieux
- QIAGEN
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Syndromic Diagnostic Test by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nucleic Acid Extraction Test
- 2.2.3 Polymerase Chain Reaction (PCR) Test
- 2.2.4 Others
- 2.3 Syndromic Diagnostic Test by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Laboratory
- 2.3.4 Research Institution
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Syndromic Diagnostic Test Breakdown Data by Type
- 3.1 Global Syndromic Diagnostic Test Historic Market Size by Type (2021-2026)
- 3.2 Global Syndromic Diagnostic Test Forecasted Market Size by Type (2027-2032)
4 Syndromic Diagnostic Test Breakdown Data by Application
- 4.1 Global Syndromic Diagnostic Test Historic Market Size by Application (2021-2026)
- 4.2 Global Syndromic Diagnostic Test Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Syndromic Diagnostic Test Market Perspective (2021-2032)
- 5.2 Global Syndromic Diagnostic Test Growth Trends by Region
- 5.2.1 Global Syndromic Diagnostic Test Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Syndromic Diagnostic Test Historic Market Size by Region (2021-2026)
- 5.2.3 Syndromic Diagnostic Test Forecasted Market Size by Region (2027-2032)
- 5.3 Syndromic Diagnostic Test Market Dynamics
- 5.3.1 Syndromic Diagnostic Test Industry Trends
- 5.3.2 Syndromic Diagnostic Test Market Drivers
- 5.3.3 Syndromic Diagnostic Test Market Challenges
- 5.3.4 Syndromic Diagnostic Test Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Syndromic Diagnostic Test Players by Revenue
- 6.1.1 Global Top Syndromic Diagnostic Test Players by Revenue (2021-2026)
- 6.1.2 Global Syndromic Diagnostic Test Revenue Market Share by Players (2021-2026)
- 6.2 Global Syndromic Diagnostic Test Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Syndromic Diagnostic Test Head Office and Area Served
- 6.4 Global Syndromic Diagnostic Test Players, Product Type & Application
- 6.5 Global Syndromic Diagnostic Test Manufacturers Established Date
- 6.6 Global Syndromic Diagnostic Test Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Syndromic Diagnostic Test Market Size (2021-2032)
- 7.2 North America Syndromic Diagnostic Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 7.4 North America Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Syndromic Diagnostic Test Market Size (2021-2032)
- 8.2 Europe Syndromic Diagnostic Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 8.4 Europe Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Syndromic Diagnostic Test Market Size (2021-2032)
- 9.2 Asia-Pacific Syndromic Diagnostic Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Syndromic Diagnostic Test Market Size (2021-2032)
- 10.2 South America Syndromic Diagnostic Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 10.4 South America Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Syndromic Diagnostic Test Market Size (2021-2032)
- 11.2 Middle East & Africa Syndromic Diagnostic Test Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Syndromic Diagnostic Test Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Abbott
- 12.1.1 Abbott Company Information
- 12.1.2 Abbott Business Overview
- 12.1.3 Abbott Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.1.4 Abbott Syndromic Diagnostic Test Product Portfolio
- 12.1.5 Abbott Recent Developments
- 12.2 Hologic
- 12.2.1 Hologic Company Information
- 12.2.2 Hologic Business Overview
- 12.2.3 Hologic Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.2.4 Hologic Syndromic Diagnostic Test Product Portfolio
- 12.2.5 Hologic Recent Developments
- 12.3 Applied BioCode
- 12.3.1 Applied BioCode Company Information
- 12.3.2 Applied BioCode Business Overview
- 12.3.3 Applied BioCode Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.3.4 Applied BioCode Syndromic Diagnostic Test Product Portfolio
- 12.3.5 Applied BioCode Recent Developments
- 12.4 Danaher
- 12.4.1 Danaher Company Information
- 12.4.2 Danaher Business Overview
- 12.4.3 Danaher Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.4.4 Danaher Syndromic Diagnostic Test Product Portfolio
- 12.4.5 Danaher Recent Developments
- 12.5 Diagenode
- 12.5.1 Diagenode Company Information
- 12.5.2 Diagenode Business Overview
- 12.5.3 Diagenode Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.5.4 Diagenode Syndromic Diagnostic Test Product Portfolio
- 12.5.5 Diagenode Recent Developments
- 12.6 Curetis
- 12.6.1 Curetis Company Information
- 12.6.2 Curetis Business Overview
- 12.6.3 Curetis Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.6.4 Curetis Syndromic Diagnostic Test Product Portfolio
- 12.6.5 Curetis Recent Developments
- 12.7 Bio-Rad
- 12.7.1 Bio-Rad Company Information
- 12.7.2 Bio-Rad Business Overview
- 12.7.3 Bio-Rad Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.7.4 Bio-Rad Syndromic Diagnostic Test Product Portfolio
- 12.7.5 Bio-Rad Recent Developments
- 12.8 DiaSorin
- 12.8.1 DiaSorin Company Information
- 12.8.2 DiaSorin Business Overview
- 12.8.3 DiaSorin Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.8.4 DiaSorin Syndromic Diagnostic Test Product Portfolio
- 12.8.5 DiaSorin Recent Developments
- 12.9 bioMérieux
- 12.9.1 bioMérieux Company Information
- 12.9.2 bioMérieux Business Overview
- 12.9.3 bioMérieux Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.9.4 bioMérieux Syndromic Diagnostic Test Product Portfolio
- 12.9.5 bioMérieux Recent Developments
- 12.10 QIAGEN
- 12.10.1 QIAGEN Company Information
- 12.10.2 QIAGEN Business Overview
- 12.10.3 QIAGEN Revenue in Syndromic Diagnostic Test Business (2021-2026)
- 12.10.4 QIAGEN Syndromic Diagnostic Test Product Portfolio
- 12.10.5 QIAGEN Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst